The Rubicon Research IPO is scheduled to open on October 9, 2025, and close on October 13, 2025, offering investors an opportunity to participate in a specialty pharmaceutical company. The Rubicon Research IPO price is between ₹461 and ₹485 per share, and the lot size is 30 shares. The total IPO size is ₹1,377.50 crore, including a fresh issue of ₹500 crore and an Offer for Sale (OFS) of ₹877.50 crore. Investors are closely monitoring the Rubicon Research IPO GMP to gauge demand and anticipate listing performance. Allotment updates and subscription details are important for retail investors who want to track their applications. The shares will be listed on BSE and NSE on October 16, 2025, providing liquidity and trading opportunities. With strong R&D capabilities, growth potential, and a transparent IPO structure, the Rubicon Research Ltd IPO remains an attractive investment option for both short-term and long-term investors.